NO20003639L - Oral oil absorbing mixture - Google Patents

Oral oil absorbing mixture

Info

Publication number
NO20003639L
NO20003639L NO20003639A NO20003639A NO20003639L NO 20003639 L NO20003639 L NO 20003639L NO 20003639 A NO20003639 A NO 20003639A NO 20003639 A NO20003639 A NO 20003639A NO 20003639 L NO20003639 L NO 20003639L
Authority
NO
Norway
Prior art keywords
oil absorbing
absorbing mixture
oral oil
oil
absorbing
Prior art date
Application number
NO20003639A
Other languages
Norwegian (no)
Other versions
NO20003639D0 (en
Inventor
Peter Watts
Stanley Stewart Davis
Original Assignee
West Pharmaceutical Service Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Service Dr filed Critical West Pharmaceutical Service Dr
Publication of NO20003639D0 publication Critical patent/NO20003639D0/en
Publication of NO20003639L publication Critical patent/NO20003639L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Det er beskrevet et olje-absorberende administrasjons- system. Systemet omfatter en olje-absorberende forbindelse og er utformet for å administrere forbindelsen til tynn- eller tykk-tarmen hos et pattedyr. Den olje- absorberende forbindelsen kan være kalsium-silikat eller mikrokrystallinsk kitosan.An oil-absorbing administration system is disclosed. The system comprises an oil-absorbing compound and is designed to administer the compound to the small or large intestine of a mammal. The oil-absorbing compound may be calcium silicate or microcrystalline chitosan.

NO20003639A 1998-01-17 2000-07-14 Oral oil absorbing mixture NO20003639L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800912.9A GB9800912D0 (en) 1998-01-17 1998-01-17 New composition
PCT/GB1999/000024 WO1999036075A1 (en) 1998-01-17 1999-01-15 Oral oil sorbing composition

Publications (2)

Publication Number Publication Date
NO20003639D0 NO20003639D0 (en) 2000-07-14
NO20003639L true NO20003639L (en) 2000-09-04

Family

ID=10825395

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003639A NO20003639L (en) 1998-01-17 2000-07-14 Oral oil absorbing mixture

Country Status (9)

Country Link
EP (1) EP1045696A1 (en)
JP (1) JP2003513000A (en)
AR (1) AR014422A1 (en)
AU (1) AU2064399A (en)
CA (1) CA2318236A1 (en)
GB (1) GB9800912D0 (en)
NO (1) NO20003639L (en)
WO (1) WO1999036075A1 (en)
ZA (1) ZA99327B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013471A2 (en) * 2001-08-08 2003-02-20 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
EP1416916B1 (en) 2001-08-16 2007-10-17 Cmp Therapeutics Limited Chitin microparticles and their medical uses
FR2838026A1 (en) * 2003-04-18 2003-10-10 Netlab FOOD SUPPLEMENT DEVICE
EP2016946B1 (en) * 2007-07-18 2013-02-27 The Jordanian Pharmaceutical Manufacturing Co. Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
EP2934495B1 (en) * 2012-12-21 2017-07-19 National Health Research Institutes Mesoporous silica nanoparticles for oil absorption
CN103756782B (en) * 2014-02-12 2015-05-20 中国农业科学院油料作物研究所 Vegetable oil preparation method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
IT1276617B1 (en) * 1995-11-24 1997-11-03 Ar Trade Invest Sa DIETETIC PREPARATION CONTAINING CHITOSAN ASSOCIATED WITH OTHER SOLUBLE FIBERS FOR THE CONTROL OF OBESITY
FI107432B (en) * 1997-02-06 2001-08-15 Novasso Oy Use of microcrystalline chitosan
JPH10306028A (en) * 1997-05-06 1998-11-17 Koji Haraguchi Drug for controlling intestinal function by lipid digestive absorbent inhibition

Also Published As

Publication number Publication date
WO1999036075A1 (en) 1999-07-22
EP1045696A1 (en) 2000-10-25
CA2318236A1 (en) 1999-07-22
JP2003513000A (en) 2003-04-08
NO20003639D0 (en) 2000-07-14
AR014422A1 (en) 2001-02-28
ZA99327B (en) 2000-09-08
GB9800912D0 (en) 1998-03-11
AU2064399A (en) 1999-08-02

Similar Documents

Publication Publication Date Title
NO986056D0 (en) Solid oral dosage forms of valsartan
FI962445A7 (en) Paroxetine tablets and method for their preparation
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
NO980729D0 (en) Procedure for reducing the acid content of crude oil
NO180474C (en) Method of potentiating the analgesic effect of curcuminoids
NO984878D0 (en) Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters
NO923405D0 (en) PROCEDURE AND DEVICE FOR AA REDUCE CONTENT OF FUEL POLLUTANTS
DE69711237D1 (en) LOCAL ANESTHETIC FOR EXTERNAL USE
NO983530D0 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
NO20003639L (en) Oral oil absorbing mixture
NO965162L (en) Substituted aralkylthioalkylthiopyridine to fight Helicobacter bacteria
NO922510L (en) PROCEDURE FOR TREATMENT OF THE CONNECTING ELEMENTS TO A GAS-STANDED MUFF PIPE CONNECTION
HUP9901673A2 (en) Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
DK0762553T3 (en) Socket connection to hospital beds
KR970041851U (en) Natural Settling Prevention Device of Hydraulic Cylinder
NO972605D0 (en) New procedure for the preparation of ranitidine
RU2002938C1 (en) Device for connection and disconnection of pipe joints
NO981594D0 (en) Treatment of infections caused by Helicobacter pylori
EP0876476A4 (en) HETEROPHILICALLY ADAPTED POULTRY VACCINE
ECSP961978A (en) 1- PHENYL- 2- DIMETHYL-AMINO - METHYL CYCLOHEXAN OL, TO PROCEDURES FOR ITS PREPARATION AND APPLICATION OF THESE COMPOUNDS IN MEDICINES
KR960016426U (en) Connection device of pipe structure
KR960031414U (en) Structure of bolt tensha pipe for two-weather twister
NO971088D0 (en) Device for forced connection of two sight lines
KR960023729U (en) Connection structure of airtight pipe
DE69618617D1 (en) COMPOSITIONS CONTAINING WISMUTH FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL COMPLAINTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application